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INTRODUCTION. 
\¥e  have  already  reported  concerning  the  effects  of the  employ- 
ment of an antimeningitis  serum, prepared in the horse by the inocu- 
lation of Diplococcus intrace[htlaris and its products, upon the course 
and termination  of a small number of cases of epidemic meningitis. 1 
The results first reported were, on the whole, so satisfactory that we 
believed  the  employment  of  the  serum  on  a  wider  scale  not  only 
justified but clearly  called  for;  and  we are now  in  position  to pre- 
sent a  second series of figures which are based upon an  analysis of 
something  more  than  400  cases  of  epidemic  meningitis  in  which 
the serum  has  been used. 
The cases of meningitis upon which this analysis rests have arisen 
in  different  and  widely  separated  parts  of  the  United  States  and 
Canada,  and  in  Great  Britain.  They have  occurred  sometimes  as 
small  epidemics,  as  in  Castalia  and  Akron,  Ohio,  in  Porterville, 
California,  and possibly in other places in the United  States,  and in 
Belfast,  Ireland,  and  Edinburgh,  Scotland;  and  sometimes  as  spo- 
radic  outbreaks  of  considerable  extent,  as  in  Cleveland,  Boston, 
Baltimore,  Cincinnati,  Philadelphia  and  New  York.  Moreover,  it 
is now evident that so-called epidemic meningitis  is widely prevalent 
throughout  the  United  States,  and  it  would  appear  to be question- 
* Received  for  publication  July  7,  19o8. 
1  Journal  of  Experimental  Medicine,  19o8, x,  141.  Independent  publications 
on  the  use  of  the  serum  have  been  made  by  Robb,  British  Medical  Journal, 
19o8,  i,  382;  by  Dunn,  Boston  Medical  and  Surgical  Journal,  19o8, clviii,  37o; 
and  Journal  of  the  American  Medical  Association,  19o8, li,  15;  by  Chase  and 
Hunt,  :Jrchives  of Internal Medicine,  19o8,  i,  294;  by  Churchill,  Journal  of  the 
American  Medical  Association~  19o8,  li,  21;  and  by  Miller  and  Barber,  idem, 
19o8,  I,  1957. 
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able whether any parts are  really free  from the  disease.  In  view 
of the fact that we have demanded that the bacteriological diagnosis 
be made in every case of meningitis for which we have supplied the 
serum,  and  which  we  have accepted  for our  analysis,  and  that  in 
doubtful  instances  we have ourselves examined stained  slides  and 
sometimes cultures prepared from the spinal exudates, we can speak 
with  positiveness  upon  this  important  subject.  Whether the wide 
distribution of the epidemic type of meningitis in the United States 
is the outcome and residue of the epidemic that raged in New York 
and  vicinity  from  19o 5  to  19o7,  or  whether the  disease  tends  to 
exist and has long existed in a  sporadic state in this country,  from 
which the severe epidemic outbreaks  have  occasionally taken their 
origin,  has  not been satisfactorily determined. 
The  mortality of  the  disease  reached during  the  height  of  epi- 
demics in the United States and in Great Britain has been about the 
same, that is,  75  per cent.  The mortality of the sporadic  form of 
the disease so far as it has prevailed in the United States on a  scale 
sufficiently large to  allow  of a  conclusion upon  this  point,  has  not 
been considerably lower than that figure, and it has sometimes been 
higher.  Dunn  2 gives a  chart in which the mortality of the disease 
is  shown  for  the  cases  treated  in  the  Boston  Children's  Hospital 
from  1899  to  19o7, before  the  antiserum  was  employed,  and  it 
ranges  from 69 to 8o per cent.  This chart also shows the striking 
fall in the curve which has been produced by the employment of the 
serum, for since the spring of 19o 7 , when the use of the serum was 
first introduced, the mortality has fallen below 2o per cent.  Menin- 
gitis  has  not  been  epidemic in  Boston  since  1897.  The epidemic, 
properly  speaking,  of  meningitis  ceased  in  New  York  with  the 
appearance of warm weather in  the spring of  19o7,  and  the cases 
of the epidemic type of the disease which have appeared since that 
time  have  arisen  sporadically.  We  have  procured  from  Dr.  S. 
J.  Baker,  of the department of health,  the case mortality statistics 
for this period.  During  19o6 when the epidemic was at its height 
lO32  cases with  812  deaths  were reported  in  Greater  New  York; 
the mortality was 78.7 per cent.  During  19o  7  when the epidemic 
was  declining 828  cases  with  642  deaths  were reported;  the mor- 
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tality  was  77.5  per  cent.  During  the  first  six  months  of  I9O8 
when the disease prevailed sporadically 253  cases  with  182  deaths 
were  reported;  the  mortality  was  71.9  per  cent.  Dr.  Baker  in- 
formed  us  that  the  case  mortality records  of  the  department  are 
less  perfect  than  the  gross  mortality records;  but  as  the  average 
error  of each  period  may be  assumed  to  be  the  same,  the  figures 
may be  accepted  as  generally correct.  No  striking  diminution in 
the fatality of the disease has therefore taken place in Greater New 
York  during  19o8  as  compared  with  the  period  corresponding to 
the  height  of  the  epidemic.  The  small  epidemic  which  prevailed 
at Akron,  Ohio,  in  19o7,  consisted of 22  cases, a  Among the first 
ten cases which occurred there were nine deaths :  a mortality of 9 ° 
per  cent.  Then  the use of the  serum  was begun,  and  it was  em- 
ployed in the next  12  cases,  of which nine recovered:  a  mortality 
of 25  per cent.  Of the three cases which were fatal one was mori- 
bund  when  first  injected  with  the  serum,  and  another  suffered  a 
fulminant attack.  The  epidemic  at  Porterville,  California,  began 
in  December,  19o  7,  and  embraced  16  cases.  4  Among  the  first 
twelve cases there was one recovery:  a  mortality of 91.6 per  cent. 
The  serum  was  employed  in  the  last  four  cases,  of  which  three 
recovered:  a  mortality of  25  per  cent.  There  was  no  difference 
observed in the manner of onset of the last  four as compared with 
the earlier cases, although their course was milder and the termina- 
tion more favorable.  The epidemics in Ireland and Scotland have 
been  of  great  severity,  and  the  mortality, before  our  serum  was 
employed, was above  7  °  per  cent.  During the  first period  of  the 
use of the serum the mortality of cases observed outside and inside 
hospitals, but treated zdthout serum, ranged from 80 to 9  °  per cent. 
The  figures  contained  in  Dr.  Robb's  report  of  71  serum-treated 
cases  give,  after  deducting the  fulminant and  moribund cases,  2o 
per  cent.,  or  including them,  26. 7  per  cent,  mortality;  Dr.  Ker's 
figures, based  on  27  cases,  are higher,  from 4o  to  44.5  per  cent., 
under the same conditions of calculation as the former. 
The analysis which is to be presented is based  upon histories of 
cases of epidemic meningitis in which the diagnosis has been estab- 
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lished by bacteriological examinations as well as by the usual clinical 
tests.  The  histories  have been  supplied by  physicians  in  hospital 
and  in  private  practice,  who  have  employed the  serum.  We  are 
under many obligations to these physicians, who so generously gave 
their time to the study of the effects of the serum.  It will not be 
possible  for  us  to  mention by  name  all  who  participated  in  the 
study.  But our special  thanks are  due Dr.  A.  Gardner  Robb,  of 
Belfast, Ireland; Dr. C. B. Ker, of Edinburgh, Scotland; Dr. L. W. 
Ladd, of Lakeside Hospital, Cleveland; Drs.  W.  T. Longcope and 
Morris  J.  Lewis,  of the Pennsylvania Hospital,  and  Dr.  Franklin 
Royer,  of  the  Municipal  Hospital,  Philadelphia;  Drs.  Charles  H. 
Dunn, John Lovett Morse, J. L. Ames and Frederic Shattuck, Bos- 
ton; Dr.  Frank Fulton, of the Rhode Island Hospital, Providence; 
Drs.  L.  F.  Barker,  Frank J.  Sladen and  Harvey  Cushing, of the 
Johns  Hopkins  Hospital,  Baltimore;  Drs.  James  D.  Morgan  and 
W.  W.  Wilkinson, of the Garfield Hospital, and Dr.  S.  S.  Adams, 
Washington; Drs.  Henry Koplik, Henry Heiman,  Morris  Manges 
and Alfred Meyer, of the Mt. Sinai Hospital, Dr. L. Emmett Holt, 
of the Babies' Hospital, Dr. C. H. Lewis, of St. Vincent's Hospital, 
Dr. G. M. Swift, of St. Mary's Hospital, Dr. George L. Peabody, of 
the New York Hospital, Drs.  Walter James, John A. Thaeher and 
W.  T.  Northrup,  of  the  Presbyterian  Hospital,  New  York;  Dr. 
Charles  W.  Duval,  of  the  Montreal  General  Hospital,  Montreal; 
Drs.  Frank S.  Churchill and Maximilian Herzog,  of Chicago; Dr. 
Alfred I.  Cole, of the City Hospital,  Cincinnati; Dr.  Philip  King 
Brown, of San Francisco, and Drs. Austin Miller and S. A. Barber, 
of Porterville; and the other physicians ";vhose names are given in 
the table, attached to the isolated cases treated by them, and to the 
hospital internes who contributed such valuable service to the carry- 
ing out of the serum injections and the making of bacteriological 
and h~ematological examinations. 
In making up the tabulations upon which the results are based, 
account has been taken of the ages and sex of the patients, the type 
of the disease, the period of the disease at which the serum was first 
injected, the days of the disease on which subsequent injections were 
made, the total amount of serum employed, the effects produced on 
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disease, upon the duration of the symptoms, the number of the diplo- 
coccus in the spinal exudate, and its viability in cultures, the general 
leucocytosis, anti the manner of recovery--that is, whether by grad- 
ual improvement of the symptoms, or lysis, or by their abrupt  ter- 
mination, or crisis--and some other details of the disease. 
We wish to state that Table  I  (see page 7ii  et seq.)  contains a 
record  of all  the  histories of cases  of  epidemic meningitis  treated 
with the  serum  which  were  received  by us  up  to  the  time  of  the 
completion of this  report,  and  that  in  making up  the  various  sta- 
tistical  tabulations  no  selection  of  cases  has  been  made  further 
than to  exclude first,  those cases  which  survived  the  first  dose  of 
the  serum  less  than twenty-four hours.  It  may, we  think, be  ac- 
cepted  as  probable  that  any marked benefit which  the  serum  may 
be  assumed to exert,  could hardly be  effectively manifested before 
the  first twenty-four hour  period  following its  administration had 
elapsed.  It  has  chanced  that  of  the  histories  here  analyzed  the 
eliminations  include  chiefly  cases  which  were  moribund  at  the 
time  of  their  admission to  hospital  and  the first serum  injections, 
and  in which the survival was  often only a  few hours.  A  second 
elimination,  embracing  a  smaller  number  of  cases,  includes  the 
rapidly  fatal  fulminant cases.  As  a  rule it is  possible  to  separate 
by  means  of  the  patients'  histories  and  the  clinical  appearances, 
the  fulminant cases  which  terminate  fatally,  from  the  moribund 
ones  which  have  only a  few  hours  to  live.  Indeed  the  propriety 
of  eliminating  the  fulminant  cases  from  the  statistical  calcula- 
tions  may  possibly  be  a  questionable  procedure,  since,  rarely,  a 
case with  fulminant onsef has  recovered under the employment of 
the  serum.  However,  in  adhering  to  our  rule  not  to  take  into 
account in calculating the percentage any case which survived a first 
serum  injection  less  than  twenty-four hours,  the  fulminant  cases 
are practically eliminated.  A  third small elimination includes sev- 
eral  cases  of  secondary and  mixed  infection  of  the  meninges,  of 
intercurrent infection  (erysipelas,  peritonitis)  which  were  the  im- 
mediate  causes  of  death,  and  hopelessly  chronic  examples  of  the 
disease in children who were moribund  after two to three months 
illness, but who survived a first serum injection longer than twenty- 
four  hours.  There  were  z I  cases  eliminated  as  moribund,  I2 Simon Flexner and  James  W.  Jobling.  695 
cases  as  fuhninant,  and  io  as  secondary  and  intercurrent  fatal 
infections, or chronically moribund. 
RESULTS ACCORDING TO  THE  AGES OF  THE  PATIENTS. 
In Table I all the cases subjected to analysis are briefly described; 
they number 421.  Of these, 43  cases were eliminated for the rea- 
sons  already stated.  Hence the  total number  of  cases  which  will 
be  subjected  to  analysis is  393,  of which  295  or  75  per  cent.  re- 
covered, and 98  , or 25  per  cent.  died.  Tabulated according to  the 
ages of the patients the following results are obtained: 
TABLE  II. 
Under I  year. 
Between I  and  •  years. 
2  "  5  ~ 
~  10  ~  20  ~ 
Over 20 years. 
Age not given. 
Total Number 
of Cases. 
22 
x9 
68 
79 
Io5 
87 
x3 
Recovered. 
II 
II 
52 
70 
8o 
64 
7 
Died.  Mortality 
Percentage. 
II  50 
8  4 2. I 
I6  23. 5 
9  II.4 
25  23.8 
23  26.4 
6  46. x 
It will be desirable to consider these figures somewhat in  detail. 
Perhaps  the  most  striking  figures  are  those  relating  to  children 
under one year of age.  Epidemic meningitis is commonly regarded 
as  being  uniformly fatal  among  infants  under  one  year.  Holt  5 
states that "  of twenty cases under one year (in his hospital wards) 
not one recovered"; and Koplik  G states that of 2  7  cases below one 
year of  age  observed  by  him  2 3  either  died,  or  were  discharged 
unimproved.  We have, therefore, made a special table of the cases 
of infants under one year of age, so that they may be more closely 
scrutinized. 
The results shown in Table III are,  indeed, not only instructive 
but  of hopeful augury.  Of  the  eleven cases  which  terminated  in 
death,  ten  were  already in  the  third  week  of  the  disease,  or  in  a 
later  stage,  even,  six  or  more  presented  well-marked  symptoms 
of  hydrocephalus,  and  one  case  only  was  in  the  first  week  of 
illness,  when  the  serum  injections  were  begun.  Of  the  eleven 
5 Holt,  Diseases  of  Infancy  and  Childhood,  19o6,  p.  763. 
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cases  which  recovered,  one  infant  was  four  weeks  old  when 
first  injected,  all  but  three  were  in  the  first  week  of  the  disease, 
and  llone  showed  symptoms  of  hydrocephalus  when  the  injec- 
TABLE  III. 
~..~  =,..~ 
.~  ~ m  ~,.~,~  ~.~ 
2  5  / M.  22  72 
3  IO  F.I  I5  35 
4  3~  M.I  20(?)  IO2 
5~  5  :[49 
6; ~I  2I  ! ~35 
7  II  F.]  49(?), 
M. 
9  6  ""*. 
6  60 
14(?)  9o(?) 
2  3 ° 
2  16 
7  75 
2I  60 
4  45 
23  45 
5  I50 
3  90 
42  I84 
6O 
7 
7 
IO  7 
tl  3 
I2  II 
131 
14  3N 
15  xi 
~6  5 
17  8 
x8  3 
~9  9 
2o  4 
2I  6 
22  7 
237[  5 
241  4 
25  I0  5 
3 ° 
47 
60 
29 
60 
30 
io8 
I34 
75 
l) 
x37t  h  Death  Cushing. 
day. 
Death  29th : Mt.  Sinai,  N.  Y. 
day.  I 
Recovered.  [  "  " 
Death  in 5th  "  " 
week. 
Death.  I Garfield,  Hosp. 
"  I New York Hosp. 
Death  II7th ] Babies' Hosp. 
day.  I 
Recovered.  I  "  " 
Death.  Lakeside Hosp. 
Recovered.  ]  "  " 
Death.  "  " 
Recovered. 
c, 
Death. 
Recovered. 
Death. 
Recovered. 
Death. 
I 
i  " 
Cincinnati Hosp. 
Dunn, Boston. 
Robb,  Belfast. 
*c  ,c 
Morse,  Boston. 
Newark  Hosp. 
Adams, Washing- 
ton. 
Bellevue,  N.  Y. 
i  Jennings,  N.  Y. 
i Ker,  Edinburgh. 
Chronic hydrocephalus  in- 
traventrieular injection. 
Semi-chronic. 
Rapid recovery. 
History imperfect ;  possibly 
later injection. 
Hydrocephalus  and  mixed 
infection on admission. 
Hydrocephalus ;  erysipelas. 
Chronic  case. 
Prompt recovery. 
Hydrocephalus  on  admis- 
sion, 
Slow recovery. 
Complicated  by  general 
oedema on admission. 
Prompt recovery. 
Semi-chronic. 
Slow recovery. 
Prompt recovery. 
Hydrocephalus.  No  fluid 
by lumbar puncture. 
Chronic case. 
Prompt recovery. 
Secondary streptococcus  in- 
fection. 
Hydrocephalus. 
Severe case. 
tions  were  begun.  Hence  the  outlook  for  favorable  effects  from 
the  serum  injections  in  infants  under  one  year  of  age  may  be 
considered hopeful,  provided  the  injections  are  begun  at  an  early 
period  of the  infection and before anatomical changes  leading to 
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hydrocephalus,  and  the  consequent  locking  up  of  infected  exudate 
in  the  cerebral ventricles,  are  established, s 
The  mortality  among  somewhat  older  children--those  ranging 
from  one  to  two  years  of  age--has  been  in  the  past  as  high  or 
almost  as  high  as  among  the  younger  infants.  Of  the  nineteen 
children in our series between the ages of one and two years, eleven 
recovered  and  eight  died.  An  analysis  of  these  shows  that  only 
one  case  injected  in  the  first  week  of  illness  died,  while  six  cases 
injected  in  the  first week,  and  five cases  injected  from  the  second 
to  the  fourth  week,  recovered.  It  is  probable  therefore  that  the 
same conditions determine  for this series as for the preceding series 
what the outcome shall be, and the chief obstacle to successful treat- 
ment by the serum injections is to be found in the greater tendency 
exhibited  by young  children  affected  with  epidemic  meningitis  to 
develop early basilar lesions leading to chronic hydrocephalus. 
The rise in recoveries and  fall in deaths in the next several series 
of  cases,  until  the  twentieth  year  is  reached,  call  for  no  special 
comment,  but  show  conclusively that  the  mortality  from  epidemic 
meningitis can be greatly reduced by the proper injection of an anti- 
serum.  We are,  indeed,  encouraged by the  figures  presented  even 
beyond what  they actually  exhibit,  since  we  believe that  the  cases 
have  not been treated  uniformly  as  well as  they might  have  been. 
As will be shown presently when we come to speak of the influence 
of  the  period  of  injection  upon  the  mode  of  termination  of  the 
disease,  one  of  the  important  factors  determining  good  results  is 
early  injection,  and  yet  in  many  cases  where  the  outcome  was  a 
good one, the injections were made late in its course.  Aside  from 
this  fact, however,  are the  additional  facts  of the  skill  with  which 
the  serum  is  injected,  and  its  proper  dosage  and  spacing,  regard- 
ing  which  there  have  been  unavoidable  discrepancies.  In  two  in- 
stances  at  least  a  fatal  termination  was  insured  and  recovery  de- 
s Possibly  even  this  condition  of  retained  infected  exudate  in  the  cerebral 
ventricles may  not  be  hopeless now  that  Cushing  and  Sladen  have  shown  the 
feasibility of direct drainage of the ventricles and  serum injection.  See Jour. of 
Exp. Med., I9o8,  x,  548.  Since  the  completion of  this  report  we  have  received 
from Dr.  Robb the histories of three cases in children under one year of age and 
one case in a  child fifteen months old, in all which the serum was iniected in the 
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feated, apparently, through the  induction from without of second- 
ary pyogenic infection of the meninges.  In one case a convalescent 
succumbed  to  a  £taphylococcus  aureus  infection  arising  from  an 
infected needle track, and in another a patient who had shown rapid 
improvement  succumbed  to  a  streptococcus  infection  also  of  ex- 
ternal origin. 
The possibility of this danger of secondary infection of the men- 
inges  from  without  should  always  be  kept  in  mind  by  those  en- 
trusted  with  the  injection  of  the  serum,  and  no  pains  should  be 
spared in disinfecting the field of operation and all objects coming 
into  contact  with  the  sermn.  Every  precaution  should  be  taken 
from the beginning, since prediction seems,  at present,  impossible, 
whether  one  or  many  injections  of  the  serum  may  be  required. 
Cases  of  marked  severity have  improved  so  rapidly after  one  in- 
jection as  not to  demand another,  and cases  apparently mild have 
called  for successive injections before responding to the treatment. 
The  general  statement may be  hazarded  that  the  milder  the  case 
and  the  earlier  the  injection  of  serum  is  made,  the  more  certain 
and more rapid the improvement; but to this statement there have 
already occurred  not  a  few  exceptions  in  which  severe  and  semi- 
chronic cases  have" responded more quickly and surely than earlier 
mild ones.  The individual factors of patients and of micro-organ- 
isms play a  part here as  in all other infective diseases with which 
we are familiar. 
In  our  first  publication  we  pointed  out  the  dangers  and  diffi- 
culties that are connected with the intradural mode of administra- 
tion  of  the  serum  which  we  then  regarded  as  essential;  and,  as 
may now be  added,  the  wider  our  experience  with  the  serum  has 
become, the more have we been convinced that the successful substi- 
tution of subcutaneous or intravenous for intraspinal injection can- 
not be accomplished. 
We  wish  to  draw  especial  attention  to  the  number  of  deaths 
among the cases  embraced  in the series  over twenty years  of age, 
since  we  believe  that  the  somewhat higher  mortality among them 
can  be  explained,  probably,  by the  fact that a  larger number than 
in other series was treated by widely scattered physicians who had 
had little or no previous experience with the serum.  If this  is  not Simon Flexner and  James  W.  Jobling.  699 
the reason, and adults of twenty years and over are less  subject to 
the  beneficial action  of  the  serum  than  younger persons,  the  fact 
will  of  course  come  out  finally; but  with  one  exception  (Cincin- 
nati City Hospital series)  wherever a  considerable number of cases 
of these ages has been treated by one person the proportion of re- 
coveries to deaths has been high.  In justice to Dr.  Cole, of Cincin- 
nati, whose general results  obtained with the serum have been  ex- 
cellent, it should be stated that many of the failures occurred in the 
early  period  of  his  employment of  the  serum  and  among  negro 
patients, the circumstances surrounding which made the most favor- 
able administration of the serum difficult.  In all Dr.  Cole treated 
with the  serum  eleven cases  over  twenty years  of  age.  Of  these 
two  were  moribund  and  died  soon  after  the  first  injection.  The 
other six  fatal cases were injected between the third and twentieth 
days of illness.  The three cases which recovered were injected in 
the first week  of illness.  These figures are  to  be  contrasted with 
those  obtained  at  the  Johns  Hopkins  Hospital,  where  of  seven 
patients over twenty years of age five recovered and two died, and 
especially with  those given by  Dr.  Robb,  of  Belfast,  who  treated 
twenty-one cases  of  these  ages,  eighteen  recovering;  and  of  the 
three fatal cases two died within twenty-four hours of the first in- 
jection of serum.  Dr.  Robb's cases are especially significant, since 
they were  treated  during  the  prevalence  of  an  epidemic  of  men- 
ingitis. 
RESULTS  ACCORDING  TO  THE  PERIOD  OF  INJECTION. 
We  have  also  analyzed  the  histories  according  to  the  earliest 
periods of the disease at which the injection of the serum was be- 
gun.  Not all the histories are perfectly definite on this point and 
hence we have used in the analysis only those that are definite.  In 
not a  few cases the onset of the disease was insidious and the pro- 
dromata  appear  to  have  been  indefinite,  and  more  or  less  over- 
looked.  At other times, and this seems to have been the more fre- 
quent  experience,  the  onset  was  abrupt,  so  that  no  special  doubt 
surrounded the beginning of the disease.  Under the circumstances, 
therefore, the danger is  that the period elapsing between the onset 
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serum  injection, will be  calculated too  short  rather  than too  long. 
It  is  very rare,  except  in the  fulminant cases,  that  one can  assure 
himself that he  is  dealing with the  disease on  the  first  day of  its 
existence. 
The  histories  of  361  cases  were  sufficiently explicit  to  enable 
us to approximate the period in which the first serum injection was 
made.  We have arbitrarily chosen the three periods which follow, 
in which to group the cases : 
Period of Injection 
of Serum. 
ISt to 3 d  day. 
4th  "7th  " 
Later than 7th day. 
I  Number of  i  Number  !  Number Died. 
Cases.  i  Recovered.  i 
Z23  I  107  1  I6 
x26  i  96  i  30 
I12  ]  73  39 
Per  Cent. 
Mortality. 
I6. 5 
23.8 
35 
In spite of the uncertainties surrounding the period of onset of 
the  symptoms, which affect the accuracy of the calculation of  the 
period,  the beneficial influence of early injection is  rendered  suffi- 
ciently  obvious  by  the  table.  The  period  embraced  in  the  last 
group  is,  of  course,  highly irregular,  since  not  a  few  cases  came 
under treatment when they were in a  semi-chronic or chronic state 
after many weeks of illness.  On the whole, therefore, the outlook 
even  for  the  latter  class  of  patients  is  not  wholly discouraging; 
and, indeed, we are of the opinion that so long as the diplococcus is 
still present  in the meningeal exudate, and the mechanical damage 
to the anatomic structure is  not irreparable, the employment of the 
serum holds out hope of considerable benefit.  In one respect cases 
coming under any treatment at the end of a  week or even a  longer 
interval since the appearance of the symptoms of meningitis, present 
the advantages which accrue  from the spontaneous elimination by 
death of the severer and rapidly-fatal examples of the disease, and 
the circumstance that some of them will already be progressing to- 
wards  recovery.  The  offset  to  these  advantages  is  to  be  found 
in  the  larger  number  of  cases  of  the  common and  severer  types, 
which, in the past, having survived the early acute stage of the dis- 
ease, developed semi-chronic and chronic lesions to which they suc- 
cumb.  Hence  in  any  considerable  number  of  cases  of  the  class 
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greatly to exceed the recoveries.  We should, therefore, expect less 
benefit to be manifested by the serum  injections which are  carried 
out  during the  later,  as  compared  with  the  earlier  periods  of  the 
infection.  In the next table  (IV)  the results of the periods of in- 
jection in the different age groups are shown. 
TABLE IV. 
Age. 
Under  I  yr. 
I  to 2  yrs. 
2  to 5  yrs. 
5  to IO yrs. 
IO to 20 yrs. 
Over 2o yrs. 
Total 
xst to :~d Day. 
L) o 
3  3  o 
3  3  o 
7  /  15  }  2  I  II'7 
8  [  35  [  3  I  8.6 
4 2  37  5  I2 
20  x4  I  6  3 ° 
~3  ~f S~ ,6S5 
4th to 7th Day. 
I 
¢9  v  ..  k3~ 
21  5  I  16. I 
4  3  I125 
34  24  IO  29. 5 
25  211  4  16 
32  26  6  23 
17  ]  8  32  25 
96  I,~3o-  23.8 
Later  Than 7th  Day. 
I2 
12 
I2 
27 
32 
II2 
86  667 
5  o 
I3 
IO  24  235  I7 
I7  IO  37 
23  9  28.1 
73  39  35 
MANNER  OF  TERMINATION  OF  THE  SYMPTOMS. 
We described in our first publication  9 on the antimeningitis serum 
the different manner in which the symptoms terminated in a  num- 
ber  of  the  serum-treated  cases,  and  we  drew  attention to  the  not 
uncommon .abrupt manner of termination to  which we applied the 
term  crisis.  We have  examined the  larger  collection of  histories 
now in our possession from the point of view of the manner of the 
recovery; that is, whether by gradual subsidence of the symptoms, 
or  lysis,  or  by the  abrupt  cessation, or  crisis.  In  considering the 
figures  which  we  will  present  as  bearing  on  this  point,  account 
should be taken of the fact that in rare instances only have the his- 
tories contained the specific statement that the symptoms terminated 
in one or the other of these ways.  In almost all instances we have 
had ourselves to make the decision, which we have done by study- 
ing  carefully the  facts  given  in  the  histories.  Hence  we  do  not 
believe  that  our  decisions  have  been  uniformly correct,  and  the 
figures  are  presented,  therefore,  merely  as  an  approximation  of 
what may be found later to be the true figures.  There can be little 
doubt that these figures will have  to  be  modified later,  in  accord- 
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ance with the wider observation and more exact and uniform judg- 
ment which will come to be  exercised.  We believe,  however,  that 
by  the  employment of  the  serum  a  new  and  very desirable  mode 
of  recovery,  to  secure  which  in  the  future every effort should  be 
made, has been effected. 
In order that recovery by crisis should be intentionally promoted 
it will be necessary, as a preliminary step, to study closely the con- 
ditions under which it has come about spontaneously in the serum- 
treated cases, so that they may be designedly imitated.  We do not 
ourselves feel able to undertake this study, which should, we think, 
be made by the clinicians themselves, but we think it desirable, im- 
perfect  as  the  present  figures  may be,  to  classify them  in  a  way 
that  may  serve  to  bring  out  their  suggestive  values.  We  have, 
therefore, brought them together in the  form of a  table  (V),  and 
arranged them according to the ages of the patients and the three 
periods of the first injection of the serum. 
TABLE V. 
Under I  yr. 
By lysis. 
By crisis. 
I  to 2  yrs. 
By  lysis. 
By crisis. 
2  to 5  yrs. 
By  lysis. 
By crisis. 
5  to  Io yrs. 
By  lysis. 
By crisis. 
IO to 2o yrs. 
By  lysis. 
By crisis. 
Over 2o yrs. 
By lysis. 
By crisis. 
First to Third  Fourth to Seventh  Later than  Total. 
Day.  Day.  Seventh Day. 
3  5 
o  o 
3  3 
o  o 
I9 
5 
15 
6 
I9 
7 
1 
Ii 
6 
io 
5 
24 
Ii 
24 
I3 
IO 
4 
io 
3 
13 
4 
x9 
4 
IO 
I 
39 
I3 
46 
20 
56 
24 
4 o 
14 
The above table  (V)  shows that of 273  cases  of epidemic men- 
ingitis treated with the serum which recovered, the termination of 
the  symptoms in  approximately 2oo  was  a  gradual  one and in  73 
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able errors of judgment in interpreting the histories, we think that 
it is probable  that this abrupt or critical cessation of the symptoms 
may take place  in  about  25  per  cent.  of  the  patients  who recover 
under the influence of the serum treatment.  Subjecting the figures 
in the table to a  still closer scrutiny, it is  found that the number of 
instances  of  lysis  and  crisis  occurring in  cases  treated  within  the 
first three days of  illness  is  in  the proportion  of  74  to  33,  on the 
fourth to seventh day, of 72 to 24, and later than the seventh day, 
of  54 to  I6.  In other words the  ratio  according to these periods 
is  2.3,  3  and  3.4  to  one  respectively.  It  will  not be profitable  to 
carry  this  analysis  further,  since  the  table  exhibits  dearly  other 
relationships and the whole number of cases is not large enough to 
warrant the making of any far-reaching deductions. 
FREQUENCY OF RELAPSES. 
It was  evident to  us,  from the study of  the first series  of cases 
treated with the serum, that a  certain number of cases,  apparently 
recovering,  would  suffer  recrudescences  of  the  disease.  At  that 
time no further statement could be ventured than that the resump- 
tion  of the serum injections promised  to  control  this  condition  of 
relapse as they had the original attack, t°  The present larger num- 
ber of  histories  has  afforded some additional  data bearing  on  the 
subject of the relapses, but they are, as affecting this subject, of very 
unequal value.  We have been able to collect from the histories  19 
examples of undoubted relapse, of which 14 terminated in recovery 
and 5  in death.  We are, therefore, encouraged to believe that the. 
early  recognition  of  the  relapses,  and  a  prompt  and  vigorous  re- 
sumption of the injections, will often arrest their progress and bring 
about a  favorable termination of the disease. 
DURATION  OF  ACTIVE  SYMPTOMS. 
Closely connected with the question of the manner of termination 
of the symptoms is the question of the duration of the active symp- 
toms of the disease in  serum-treated as compared with non-serum- 
treated cases.  In view of the relatively large number of the former 
cases  in  which  the  symptoms  cease  abruptly,  the  fact  is  open  to 
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prediction that the average duration in days, of the active symptoms 
of any considerable number of the cases, will be smaller than of a 
similar  number  of cases  which  had  not  the benefit  of  the  serum. 
We  have  analyzed  228  histories,  in  which  the  data  covering this 
point  are  pretty  complete,  with  reference to  the  duration  of  the 
fever and the usual subjective and special objective symptoms among 
patients  who  recovered, and  found  the  period  to  be  about  eleven 
days. 
This  period,  it  should  be  stated,  embraces not  the  entire  time 
during which the patients were under observation in  hospitals  and 
private  Practice before  their  discharge,  but  it  covers  the  interval 
during which they presented active symptoms of illness.  Hence it 
has happened that the interval has not infrequently been estimated 
as only a  few days in length, although the recovery of lost strength 
and the ability to resume the ordinary vocations took a much greater 
number of days. 
INFLUENCE  ON  DIPLOCOCCI. 
In our first publication on the serum treatment of epidemic men- 
ingitis we drew attention to a  fact, which impressed us as remark- 
able and significant, namely, that very soon  after the serum injec- 
tions were begun the diplococci tended to be greatly reduced in num- 
bers,  to  disappear  from  the  fluid  part  of  the  exudate,  to  become 
wholly intracellular  (unless they were already entirely absent),  to 
present certain changes in appearance, as  swelling and  fragmenta- 
tion,  and  to  stain  diffusely and  indistinctly,  and  coincidentally to 
lose viability in  cultures.  The later  and  far  wider experience has 
tended to confirm the views we first expressed, based on the effects 
observed;  and  while exceptions occur  in  which the diplococci  dis- 
appear or become engulfed and change in morphology or lose via- 
bility more slowly, yet the general  fact of the profound and rapid 
injury exerted upon the diplococci by the serum seems securely estab- 
lished.  There  seems little  doubt  that  part  of  the beneficial effect 
of the serum injections must arise from the restriction of multipli- 
cation and from the greater phagocytosis of the diplococci. 
We  have  indicated  in  our  main  table  (I),  under  the  heading 
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spinal exudate was in cases in which the serum was injected, and in 
which adequate observations were made on the number, appearance, 
location, and viability of the diplococci.  By the phrase " rapid "  or 
" prompt  disappearance  and loss of viability "  of the diplococci, we 
mean  that  after the first,  second or third  serum injection  they were 
greatly  reduced  in  numbers  and  lost  power to  grow  on  favorable 
culture media,  and by the term  "slow loss of viability"  or  "grad- 
ual"  or "slow disappearance,"  we mean that  the diplococci showed 
themselves  more  resistant  to  the  serum.  Perhaps  the  strongest 
impression  of  the  rapidly  injurious  action  of  the  serum  upon  the 
diplococci will be brought out by a  simple  statement of the  number 
of  instances  in  which,  recovery having  taken  place,  the  diplococci 
were  affected  in  this  "rapid,"  or  "prompt,"  and  in  this  "slow" 
manner.  The  records  in  the  histories  of  IIO  cases  are  sufficiently 
complete to admit of a  decision upon the  fate of the diplicocci;  and 
we  have  therefore  ascertained  that  in  IOO  cases  the  diplococci 
disappeared  and  lost  viability quickly,  and  in  Io cases  slowly. 
Perhaps  a  word  should  be  added  on  the  question  of  the  value 
as evidence of the observed loss of power of the diplococci to grow 
in the cultures,  on their  capacity to multiply in  a  restricted  manner 
in  the  meningeal  exudate.  We  believe  that  there  is  no  absolute 
agreement  between the  facts regarding  cultivation  outside the ner- 
vous  system  and  capacity  for  growth  in  the  meninges.  Instances 
have been observed  (Presbyt.  Hosp.  Case 2,  etc.)  in  which  relapse 
of symptoms was ushered in, or attended by, increase in the number 
and  resumption  of  normal  appearance  of  the  diplococci, which  yet 
did not grow in cultures, although the medium was otherwise favor- 
able to the diplococcus.  It is of course in no degree surprising,  but 
quite  what  should,  in  view  of  the  anatomical  conditions  present. 
be expected, that after complete disappearance of the diplococci from 
the spinal exudate they should sometimes reappear.  The resolution 
of the fibrino-purulent exudate must often proceed slowly, and until 
it  is  complete  the  diplococci  must  often  find  favorable  niches 
in  which  to  survive  and  even  to multiply.  From  such  active  foci 
the  reinfections,  with  which  the  relapses  are  associated,  probably 
take place.  In  the  fatal  cases the  diplococci are  often  more  resis- 
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little  influenced  by them.  The  viability under  these  circumstances 
is  likely also  to  be retained. 
The opportunities for such cryptic survival of the diplococci prob- 
ably  explain  the  exceptional  instances  in  which  the  symptoms  and 
the character  of the  spinal  exudate  leave no doubt of the  existence 
of  acute  (epidenaic?)  meningitis,  but  in  which  there  is  failure  to 
demonstrate  the  diplococci at  the first lumbar  puncture,  or even  at 
all in cases which recover rapidly. 
INFLUENCE  ON  SPINAL  EXUDATE  AND  LEUCOCYTOSIS. 
Attention was previously directed by us to the rapidity with which 
the  exudate  in  the  meninges  loses  turbidity  under  the  influence  of 
the  serum  injections. 11  This  fact has  been noted  again  and  again 
in  the  subsequent  cases treated  with  the serum.  Indeed,  it  would 
now appear as if the  fear we expressed that  the cases with  strictly 
purulent exudates might be less amenable to the action of the serum 
was premature.  A  fair number of cases (see Table I)  in which the 
notes state the spinal exudate to have been purulent, have recovered, 
and  the  rapid  clearing  of  the  exudate  was  observed even  in  them. 
Whether  there  is  complete anatomical  restitution  of  the  meninges 
in these cases can only be determined by post-mortem examinations ; 
but that  complete  functional  restoration  can  take place  may be re- 
garded as  established. 
Closely connected with the rapidity with which the cerebro-spinal 
exudate loses pus cells and  returns to a  limpid condition  is the state 
of the general leucocytes of the blood.  If the inflammatory emigra- 
tion  is  arrested  by the  serum  injections,  then  the number  of  circu- 
lating leucocytes should tend rapidly to return  to the normal.  The 
facts at hand, based upon many counts of the circulating leucocytes, 
only  a  few  representative  ones  of  which  can  be  reproduced  here, 
made before the injections of the serum were begun, and afterwards 
at regular  intervals,  show, as was to be expected, in  favorable cases 
going  on  to recovery, a  fall,  often very rapid  and  even  critical,  in 
the  number  of  leucocytes in  the  general  blood  stream  with  which 
the  disappearance  of  the  diplococci  and  the  clearing  of  the  spinal 
exudate are correlated. 
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Case.  ] Age. 
Johns Hop-  6 yr. 
kins Hos- 
pital  No. : 
I.  i 
IdemI4. No.  I I yr. 
Idem No.  '5 yr. 
'9. 
Mt. Sinai  I4 yr. 
NO.  II. 
St.  Mary's  I2 yr. 
Hospital 
No. 2. 
Penns.yl-  23 yr. 
vanla 
Hospital 
No.  9. 
Before 
Injection. 
21,0OO 
(Dec. 24). 
37,6OO 
(Dec. 28). 
4  ° , 600 
(Apr. 2). 
44,000 
(May 2o). 
32,600 
(Mar.  ,o). 
47,500 
(Mar.  21). 
23,35o 
(May '4). 
20,65o 
(May 16). 
After First  After Second 
Injection.  _  Injection.  _ 
Serum,  I  Serum, 
Dec. 3  o.  Dec. 3 x. 
15,6oo  I  20,400 
(Dec.  3I)"  [  (Jan.  2). 
Serum, 
Apr.  2. 
31,200 
(Apr. 3). 
Serum, 
May 2o. 
26,4oo 
(May 21). 
Serum, 
Mar.  II. 
28,000 
(Mar.  12). 
25,000 
(Mar. x3). 
Serum, 
Mar. 2I. 
]No count. 
Serum, 
May x6. 
10,550 
(May I7). 
12,O50 
(May I9). 
IO,6OO 
(May 20). 
I2,5C0 
(May 2x). 
Serum, 
Apr. 3. 
I3,4oo 
(Apr. 5). 
Serum, 
May 21. 
6,4OO 
(May 24). 
Serum, 
Mar.  13. 
I6,ooo 
(Mar.  I4). 
15,ooo 
(Mar.  16). 
Serum, 
Mar.  22. 
q2,500 
(Mar.  23). 
Serum, 
May 2I. 
24,95 ° 
(May 22). 
After Third  Result. 
Injection. 
Serum,  Recovered. 
Jan. 2. 
8,000 
(Jan.  23). 
Recovered 
by crisis. 
Recovered 
by crisis. 
Recovered. 
Recovered 
by crisis. 
Serum,  Recovered 
May 22. 
x2,45 o 
(May 23). 
IO,9OO 
(May 24). 
9,600 
(May 25). 
13,4oo 
(May 26). 
,0,750 
(May 27). 
,o,85o 
(June 9). 
It has been stated already that  during the relapses,  and possibly 
as ushering them in, the spinal  exudate becomes more turbid,  with 
which condition there is correlated an increase in the systemic leuco- 
cytosis, as is shown by the  following example  (p.  7o8). 
The reverse of the phenomena here mentioned is encountered in 
those cases not responding to the serum, or responding imperfectly, 
in  which  death  is  the  result.  Although  the  data  bearing  on  this 
topic at our command are less numerous and perfect than the other, 
yet the general statement can he made that the diplococci, the spinal 
exudate,  and  the  circulating  leucocytes  are  less  influenced  in  the 708  Epidemic  Meningitis  Treated  with  Serum. 
t'o..  [  a.o  [  Before  AfterFirst  [Alters ....  d  After Third l After Later  l  ...... 
......  s~-  Injection.  I  Injection.  [  Injection.  Injection.  [ Injections.  ]  ........ 
Presbyterian  I 4 yrs. I  No count.[  Serum  Serum  Serum  Serum 
Hospital, N.Y.  Jan.  25.  Jan.  27.  Jan.  29.  Jan.  3  o. 
No. 2.  I  39,7oo  22,5oo  16,4co  22,50o 
(Jan.  26)  (Jan. 29)  Jan.  3  ° .  (Feb,  I) 
]  34,8oo  Serum 
(Jan. 27)  Feb. 2. 
17,3oo  Relapse 
(Feb.  3)  with 
25,2002  recovery. 
(Feb. 4) 
Serum 
Feb. 4. 
28) 20012 
[Feb.  6) 
Serum 
Feb. 6. 
2~2C0 
'Feb. 7) 
Serum 
Feb.  7. 
19, IOO 
'Feb. 8) 
Serum 
Feb. 8. 
14,o00 
'Feb. 9) 
Serum 
Feb.  Io. 
,3,5ool 
(feb.  ,,)! 
9,900 
(Feb.  '5} 
resistant cases, and that progressive increase in turbidity of the exu- 
date,  and rise  in leucocytosis, and greater persistance of the diplo- 
cocci, with retention of viability, are unfavorable indications.  The 
relation  of  a  persistently  high or  increasing  systemic leucocytosis, 
and an unfavorable termination of the disease is shown by the next 
examples  (p.  7o9). 
FREQUENCY  OF  PERMANENT  SEQUEL2E. 
The  indications which  were  given by the  first  series  of  serum- 
treated  cases  were  to  the  effect that the  recoveries,  as  the  rule to 
which the  exceptions would  not  be  numerous, would  be  complete. 
The facts brought out by the far larger series of cases on which this 
article is  based confirm the earlier view which we expressed.  The 
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Case. 
New York Hos- 
pital, No.  L 
Cincinnati Hos 
pital, No. 26. 
Adams,  Wash- 
ington, No. I. 
Age. 
t8 too. 
I7 yr. 
5 yr. 
Before 
Injection. 
30,000 
(Dec. 2). 
25~O00 
(Mar. 3I). 
No count. 
After xst 
Injection. 
Serum, 
Dec. 2. 
20,400 
(Dec. 3)" 
Sel'um~ 
Mar.  3 L 
21  ~000 
Apr.  I ). 
16,2OO 
Apr. 2). 
Serum, 
Feb.  I L 
After 2d  After 3  d 
Injection.  Injection. 
Serum,  Serum, 
Dec. 3.  Dee. 4. 
22,000  21,800 
(Dec. 41  (Dec. 6) 
Serum,  Serum, 
Apr.  2.  Apr. 4. 
I6,46o  Io,73  o 
(Apr. 41  (Apr. 6) 
26,000 
(Apr. 71 
28,200  Serum, 
(Feb. 13  Feb. I4 
26,400 
(Feb. x  5 
After Later 
Injections. 
Sernm, 
Apr. 7. 
28,666 
(Apr. 8). 
26,200 
(Apr. 9). I 
25,400 
(Apr. xo). 
31,46o 
(Apr. Ix). 
29,800 
(Feb. I6). 
Serum, 
Feb.  I6. 
42,400 
(Feb. 18). 
59,2oo 
(Feb. 2o). 
Serum, 
Feb. 2o. 
Serum, 
Feb.  22. 
Serum, 
Feb. 24  . 
57,40o 
(Feb. 26 ~. 
Result. 
Died. 
Died. 
Died. 
complications  of  a  serious  character,  arising  during  and  as  a  re- 
sult  of  the  meningeal inflammation,  which  remained permanently 
after  the  infection  and  inflammation  subsided,  have  been  few. 
There are noted in the histories deafness seven times, blindness and 
deafness once  (in an infant in whom they were already present on 
the  twenty-second  day,  when  first  injected),  mental  impairment 
once, and choroiditis once.  The condition of deafness was, almost 
invariably, noted early in the disease, and  several times before the 
serum injections were begun. 
CONCLUSION. 
It is our belief that the analyses of histories of cases of epidemic 
meningitis  which have been  presented  in  this  article  furnish  con- 
vincing proof that the antimeningitis serum when used by the sub- 710  Epidemic  Meningitis  Treated  with  Serum. 
dural method of injection, in suitable doses and at proper intervals, 
is capable of reducing the period of illness; of preventing, in large 
measure, the chronic lesions and types of the infection; of bringing 
about complete restoration to health, in all but a very small number 
of the recovered, thus lessening the serious, deforming, and perma- 
nent consequences of  meningitis; and  of  greatly  diminishing the 
fatalities due to the disease. Simon  Flexner  and  James  W.  Jobling.  711 
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